Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Tenaya Therapeutics stock
Learn how to easily invest in Tenaya Therapeutics stock.
Tenaya Therapeutics Inc is a biotechnology business based in the US. Tenaya Therapeutics shares (TNYA) are listed on the NASDAQ and all prices are listed in US Dollars. Tenaya Therapeutics employs 135 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Tenaya Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TNYA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Tenaya Therapeutics stock price (NASDAQ: TNYA)Use our graph to track the performance of TNYA stocks over time.
Tenaya Therapeutics shares at a glance
|Latest market close||$2.90|
|52-week range||$3.06 - $32.00|
|50-day moving average||$4.63|
|200-day moving average||$9.28|
|Wall St. target price||$26.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.27|
Buy Tenaya Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Tenaya Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tenaya Therapeutics price performance over time
|1 week (2022-09-26)||-8.23%|
|1 month (2022-09-02)||-36.40%|
|3 months (2022-07-01)||-46.79%|
|6 months (2022-04-01)||-76.80%|
|1 year (2021-10-01)||-86.81%|
|2 years (2020-09-29)||N/A|
|3 years (2019-09-29)||N/A|
|5 years (2017-09-29)||N/A|
Tenaya Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-31.56%|
|Return on equity TTM||-58.34%|
|Market capitalisation||$134 million|
TTM: trailing 12 months
Tenaya Therapeutics share dividends
We're not expecting Tenaya Therapeutics to pay a dividend over the next 12 months.
Tenaya Therapeutics overview
Tenaya Therapeutics, Inc. , a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California. .
Frequently asked questionsWhat percentage of Tenaya Therapeutics is owned by insiders or institutions?
Currently 6.265% of Tenaya Therapeutics shares are held by insiders and 90.558% by institutions. How many people work for Tenaya Therapeutics?
Latest data suggests 135 work at Tenaya Therapeutics. When does the fiscal year end for Tenaya Therapeutics?
Tenaya Therapeutics's fiscal year ends in December. Where is Tenaya Therapeutics based?
Tenaya Therapeutics's address is: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Tenaya Therapeutics's ISIN number?
Tenaya Therapeutics's international securities identification number is: US87990A1060
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert